Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.

Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI.

Biol Psychiatry. 2008 Sep 15;64(6):468-75. doi: 10.1016/j.biopsych.2008.04.022. Epub 2008 Jun 5.

PMID:
18534556
2.

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.

Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI.

Biol Psychiatry. 2008 Sep 1;64(5):361-8. doi: 10.1016/j.biopsych.2008.03.004. Epub 2008 Apr 23.

PMID:
18436195
3.

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR; BOLDER II Study Group.

J Clin Psychopharmacol. 2006 Dec;26(6):600-9. Erratum in: J Clin Psychopharmacol. 2007 Feb;27(1):51.

PMID:
17110817
4.

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.

Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W; BOLDER Study Group.

Bipolar Disord. 2007 Jun;9(4):413-25.

PMID:
17547587
5.

Bipolar depression: a new role for atypical antipsychotics?

Keck PE Jr.

Bipolar Disord. 2005;7 Suppl 4:34-40. Review.

PMID:
15948765
6.
7.

The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.

Berk M, Dean OM, Cotton SM, Jeavons S, Tanious M, Kohlmann K, Hewitt K, Moss K, Allwang C, Schapkaitz I, Robbins J, Cobb H, Ng F, Dodd S, Bush AI, Malhi GS.

J Clin Psychiatry. 2014 Jun;75(6):628-36. doi: 10.4088/JCP.13m08454.

8.

Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.

Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M.

J Affect Disord. 2008 Dec;111(2-3):306-19. doi: 10.1016/j.jad.2008.06.019. Epub 2008 Sep 5.

PMID:
18774180
9.

A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder.

Marangell LB, Suppes T, Zboyan HA, Prashad SJ, Fischer G, Snow D, Sureddi S, Allen JC.

J Clin Psychiatry. 2008 Feb;69(2):183-9.

PMID:
18211128
10.

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.

Bipolar Disord. 2009 Aug;11(5):483-93. doi: 10.1111/j.1399-5618.2009.00728.x.

PMID:
19624387
11.

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.

Zhang ZJ, Kang WH, Li Q, Tan QR.

J Psychiatr Res. 2007 Nov;41(10):828-36. Epub 2006 Sep 29.

PMID:
17010995
12.

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.

Magalhães PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M.

J Affect Disord. 2011 Mar;129(1-3):317-20. doi: 10.1016/j.jad.2010.08.001. Epub 2010 Aug 30.

PMID:
20800897
13.

Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.

Saricicek A, Maloney K, Muralidharan A, Ruf B, Blumberg HP, Sanacora G, Lorberg B, Pittman B, Bhagwagar Z.

J Clin Psychiatry. 2011 Jun;72(6):744-50. doi: 10.4088/JCP.09m05659gre. Epub 2010 Oct 19.

PMID:
21034692
14.
15.

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.

Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE Jr, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.

J Affect Disord. 2009 Jun;115(3):376-85. doi: 10.1016/j.jad.2008.10.005. Epub 2008 Nov 29.

PMID:
19042026
16.

Inositol augmentation of lithium or valproate for bipolar depression.

Eden Evins A, Demopulos C, Yovel I, Culhane M, Ogutha J, Grandin LD, Nierenberg AA, Sachs GS.

Bipolar Disord. 2006 Apr;8(2):168-74.

PMID:
16542187
17.

A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression.

Loo CK, Mitchell PB, McFarquhar TF, Malhi GS, Sachdev PS.

Psychol Med. 2007 Mar;37(3):341-9. Epub 2006 Dec 19.

PMID:
17176505
18.

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, Bowden CL, Soares JC.

Hum Psychopharmacol. 2008 Mar;23(2):87-94. doi: 10.1002/hup.912.

PMID:
18172906
19.

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

Zarate CA Jr, Payne JL, Singh J, Quiroz JA, Luckenbaugh DA, Denicoff KD, Charney DS, Manji HK.

Biol Psychiatry. 2004 Jul 1;56(1):54-60.

PMID:
15219473
20.

A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life.

Endicott J, Rajagopalan K, Minkwitz M, Macfadden W; BOLDER Study Group.

Int Clin Psychopharmacol. 2007 Jan;22(1):29-37.

PMID:
17159457

Supplemental Content

Support Center